Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=246"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=246

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02570126-sae",
        "title": "VAR_HSA_F Group vs VAR Group: serious adverse events",
        "summary": "13 of 615 against 15 of 616; risk difference -0.3 points, 95% interval -2.1 to 1.4; NCT02570126, A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.",
        "record": "/library/comparisons/NCT02570126-sae",
        "nct_id": "NCT02570126",
        "kind": "serious-adverse-events",
        "participants": 1231,
        "risk_difference": {
          "value": -0.0032124379685355316,
          "lower": -0.020952084673395006,
          "upper": 0.014302332358927652
        },
        "group_1": "13 of 615",
        "group_2": "15 of 616",
        "difference": "-0.3 points",
        "interval": "-2.1 to 1.4",
        "trial_title": "A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age."
      },
      {
        "id": "NCT00538785-a6378fe3",
        "title": "Motavizumab (MEDI-524) vs Palivizumab: Number of Subjects Reporting Adverse Events Through Study Day 150",
        "summary": "575 of 618 against 566 of 612; risk difference 0.6 points, 95% interval -2.4 to 3.5; NCT00538785, A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease",
        "record": "/library/comparisons/NCT00538785-a6378fe3",
        "nct_id": "NCT00538785",
        "kind": "outcome",
        "participants": 1230,
        "risk_difference": {
          "value": 0.005584110666920439,
          "lower": -0.023703193852566907,
          "upper": 0.03500668760360271
        },
        "group_1": "575 of 618",
        "group_2": "566 of 612",
        "difference": "0.6 points",
        "interval": "-2.4 to 3.5",
        "trial_title": "A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=247",
  "request_id": "iwFKvnpHDNWQWBqX"
}